BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romeo R, Colombo M. The natural history of hepatocellular carcinoma. Toxicology. 2002;181-182:39-42. [PMID: 12505282 DOI: 10.1016/s0300-483x(02)00252-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, Buonaguro L, Marincola FM, Wang E, Buonaguro FM. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. J Transl Med 2009;7:85. [PMID: 19821982 DOI: 10.1186/1479-5876-7-85] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
2 Di Vuolo V, Buonaguro L, Izzo F, Losito S, Botti G, Buonaguro FM, Tornesello ML. TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infect Agent Cancer. 2011;6:13. [PMID: 21843334 DOI: 10.1186/1750-9378-6-13] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
3 Kho VK, Chen WC. Hepatocellular carcinoma presenting as radiculopathy. J Clin Oncol 2007;25:1805-6. [PMID: 17470874 DOI: 10.1200/JCO.2006.09.9036] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Mazzanti R, Messerini L, Comin CE, Fedeli L, Gannè-Carrie N, Beaugrand M. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. World J Gastroenterol 2007; 13(37): 5009-5014 [PMID: 17854145 DOI: 10.3748/wjg.v13.i37.5009] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
5 Son G, Kremer M, Hines IN. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract. 2010;2010:453563. [PMID: 20706692 DOI: 10.1155/2010/453563] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
6 Li X, Shi ZM, Feng P, Wen ZY, Wang XJ. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis. World J Gastroenterol 2007; 13(31): 4192-4198 [PMID: 17696247 DOI: 10.3748/wjg.v13.i31.4192] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
7 De Giorgi V, Buonaguro L, Worschech A, Tornesello ML, Izzo F, Marincola FM, Wang E, Buonaguro FM. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One 2013;8:e56153. [PMID: 23441164 DOI: 10.1371/journal.pone.0056153] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
8 Klein PJ, Schmidt CM, Wiesenauer CA, Choi JN, Gage EA, Yip-Schneider MT, Wiebke EA, Wang Y, Omer C, Sebolt-Leopold JS. The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer. Neoplasia 2006;8:1-8. [PMID: 16533420 DOI: 10.1593/neo.05373] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]